{"entity":{"type":"insider","cik":"0001644160","url":"/insider/0001644160","json_url":"/insider/0001644160.json","name":"SVLSF V, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":3,"first":"2015-06-30","last":"2019-05-30","span_basis":"filed_date"},"name_variants":[{"name":"SVLSF V, LLC","source":"filing","n_filings":3,"first_seen":"2015-06-30","last_seen":"2019-05-30"}],"transactions":[{"id":7912711,"accession":"0001104659-19-032917","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-19-032917","line_url":"/filing/0001104659-19-032917#line-6","is_derivative":false,"issuer_cik":"0001460732","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001460732","owner_cik":null,"owner_name":"SV Life Sciences Fund V (GP), LP; SV LIFE SCIENCES FUND V LP; SVLSF V, LLC; SV Life Sciences Fund V Strategic Partners, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":377732.0,"shares_display":"377,732","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":5288248.0,"total_display":"5,288,248.00","shares_owned_after":1875637.0,"shares_owned_after_display":"1,875,637","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-28","filed_date":"2019-05-30","scope":"insider"},{"id":7912708,"accession":"0001104659-19-032917","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-19-032917","line_url":"/filing/0001104659-19-032917#line-5","is_derivative":false,"issuer_cik":"0001460732","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001460732","owner_cik":null,"owner_name":"SV Life Sciences Fund V (GP), LP; SV LIFE SCIENCES FUND V LP; SVLSF V, LLC; SV Life Sciences Fund V Strategic Partners, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7983.0,"shares_display":"7,983","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":111762.0,"total_display":"111,762.00","shares_owned_after":39637.0,"shares_owned_after_display":"39,637","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-28","filed_date":"2019-05-30","scope":"insider"},{"id":5202335,"accession":"0000899243-17-027009","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000899243-17-027009","line_url":"/filing/0000899243-17-027009#line-14","is_derivative":false,"issuer_cik":"0001460732","issuer_name":"Arsanis, Inc.","issuer_ticker":"ASNS","issuer_name_source":null,"issuer_url":"/issuer/0001460732","owner_cik":null,"owner_name":"SV Life Sciences Fund VI Strategic Partners, L.P.; SV Life Sciences Fund V Strategic Partners, L.P.; SV Life Sciences Fund VI, L.P.; SVLSF V, LLC; SV LIFE SCIENCES FUND V LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":483448.0,"shares_display":"483,448","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":4834480.0,"total_display":"4,834,480.00","shares_owned_after":1852409.0,"shares_owned_after_display":"1,852,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-20","filed_date":"2017-11-20","scope":"insider"},{"id":5202329,"accession":"0000899243-17-027009","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000899243-17-027009","line_url":"/filing/0000899243-17-027009#line-13","is_derivative":false,"issuer_cik":"0001460732","issuer_name":"Arsanis, Inc.","issuer_ticker":"ASNS","issuer_name_source":null,"issuer_url":"/issuer/0001460732","owner_cik":null,"owner_name":"SV Life Sciences Fund VI Strategic Partners, L.P.; SV Life Sciences Fund V Strategic Partners, L.P.; SV Life Sciences Fund VI, L.P.; SVLSF V, LLC; SV LIFE SCIENCES FUND V LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16552.0,"shares_display":"16,552","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":165520.0,"total_display":"165,520.00","shares_owned_after":1868961.0,"shares_owned_after_display":"1,868,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-20","filed_date":"2017-11-20","scope":"insider"},{"id":8915007,"accession":"0001104659-15-049016","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-15-049016","line_url":"/filing/0001104659-15-049016#line-6","is_derivative":false,"issuer_cik":"0001454789","issuer_name":"CATABASIS PHARMACEUTICALS INC","issuer_ticker":"CATB","issuer_name_source":null,"issuer_url":"/issuer/0001454789","owner_cik":null,"owner_name":"SV LIFE SCIENCES FUND V LP; SV Life Sciences Fund V Strategic Partners, L.P.; SVLSF V, LLC; SV Life Sciences Fund V (GP), LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":382996.0,"shares_display":"382,996","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":4595952.0,"total_display":"4,595,952.00","shares_owned_after":2798528.0,"shares_owned_after_display":"2,798,528","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-30","filed_date":"2015-06-30","scope":"insider"},{"id":8915005,"accession":"0001104659-15-049016","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-15-049016","line_url":"/filing/0001104659-15-049016#line-5","is_derivative":false,"issuer_cik":"0001454789","issuer_name":"CATABASIS PHARMACEUTICALS INC","issuer_ticker":"CATB","issuer_name_source":null,"issuer_url":"/issuer/0001454789","owner_cik":null,"owner_name":"SV LIFE SCIENCES FUND V LP; SV Life Sciences Fund V Strategic Partners, L.P.; SVLSF V, LLC; SV Life Sciences Fund V (GP), LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8094.0,"shares_display":"8,094","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":97128.0,"total_display":"97,128.00","shares_owned_after":59139.0,"shares_owned_after_display":"59,139","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-30","filed_date":"2015-06-30","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001761612","name":"BICYCLE THERAPEUTICS plc","url":"/issuer/0001761612","role":"Ten percent owner","n_filings":1,"first_seen":"2019-05-30","last_seen":"2019-05-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001501697","name":"Arsanis, Inc.","url":"/issuer/0001501697","role":"Ten percent owner","n_filings":1,"first_seen":"2017-11-20","last_seen":"2017-11-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001454789","name":"CATABASIS PHARMACEUTICALS INC","url":"/issuer/0001454789","role":"Ten percent owner","n_filings":1,"first_seen":"2015-06-30","last_seen":"2015-06-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001644160","retrieved_at":"2026-08-22T03:37:08+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}